Bronchiectasis: new therapies and new perspectives
European Respiratory Society guidelines for the management of adult bronchiectasis highlight the paucity of treatment options available for patients with this disorder. No treatments have been licensed by regulatory agencies worldwide, and most therapies used in clinical practice are based on very l...
Main Authors: | Chalmers, James D, Chotirmall, Sanjay Haresh |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Journal Article |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/87984 http://hdl.handle.net/10220/44510 |
Similar Items
Similar Items
-
RESPIRE : breathing new life into bronchiectasis
by: Chalmers, James D., et al.
Published: (2019) -
Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis
by: Chandrasekaran, Ravishankar, et al.
Published: (2018) -
Microbiology and the microbiome in bronchiectasis
by: Mac Aogáin, Micheál, et al.
Published: (2023) -
Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways
by: Chotirmall, Sanjay Haresh, et al.
Published: (2017) -
Clinical Aspergillus signatures in COPD and bronchiectasis
by: Tiew, Pei Yee, et al.
Published: (2022)